Galectin-3 inhibition using novel inhibitor GR-MD-02 improves survival and immune function while reducing tumor vasculature. Issue 2 (December 2015) - Linch, Stefanie; Kasiewicz, Melissa; McNamara, Michael; Hilgart, Ian; Farhad, Mohammad; Redmond, William